J&J to buy cardiovascular technology Abiomed in $16.6 billion deal ...Middle East

Johnson and Johnson will spend USD 16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division. The health care giant said on Tuesday that it will pay USD 380 for each Biomed share and also provide another USD 35 per share in cash if some commercial and clinical milestones are met. Abiomed develops technology that treats coronary artery disease and heart failure.

Hence then, the article about j j to buy cardiovascular technology abiomed in 16 6 billion deal was published today ( Tuesday 01/11/2022 - 02:32 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( J&J to buy cardiovascular technology Abiomed in $16.6 billion deal )

Also on site :

• Texas Launches $350 Million Nuclear Energy Initiative
• Africa: TECNO Brings Immersive Fan Experience to AFCON 2025 with Pop-Up Stores and Interactive Zones Across Morocco
• National Oil Companies Quietly Set The Pace For The Next Decade